INTRODUCTION
showed that several enzymes whose natural substrates are phosphoric monoesters can act on unphosphorylated substrates in the presence of arsenate. It is likely that the esters of arsenate form in the active sites of the enzymes, because of the ease with which such esters form and hydrolyse (Braunstein, 1931) :
R-OH+HAsO42-= R-0-AsO2-+H2o
The high rate of esterification and de-esterification of arsenate in comparison with phosphate is due to the easier access of a fifth ligand to the larger central atom. Several examples of such enzyme-catalysed transformations of alkyl arsenates are now known, e.g. of glucose 6-arsenate (Long & Ray, 1973; Lagunas, 1970 Lagunas, , 1980 and of adenosine 5'-arsenate (Lagunas et al., 1984) . If a solution of preformed ester of arsenic acid is used, the enzyme-catalysed reactions may be rapid (Lagunas, 1970; Long & Ray, 1973 ), but such esters are unstable, and hydrolyse with a half-life of less than 1 h under physiological conditions (Lagunas, 1980; Lagunas et al., 1984) . (Acylated or phosphorylated arsenates are much less stable, with half-lives of about 1 s; Gresser, 1981; Moore et al., 1983; Slooten & Nuyten, 1983.) 
MATERIALS AND METHODS

Aspartate aminotransferase
The enzyme was partially purified from pig heart by a modification of the method of Jenkins et al. (1959) and MartinezCarrion et al. (1967) . Their first four steps, extraction, heat treanilent, precipitation with (NH4)2SO4, and dialysis, gave a product suitable for most of the work. In the first step we used 3 mM-succinic acid/47 mM-disodium succinate buffer instead of the maleate/EDTA buffer originally proposed in order to avoid damage caused by heating with maleate (Turano et al., 1964) .
The preparation obtained showed a specific activity in the assay of 17 #smol min-' mg-'. For spectroscopy, the a-subform of the Vol. 284 enzyme was separated from this by a modification of the method of Martinez-Carrion et al. (1967) . A gradient from 40 misodium acetate, pH 5.2 (i.e. 9 mM-acetic acid/31 mM-sodium acetate) to 100 mM-sodium acetate, pH 5.4 (i.e. 15 mM-acetic acid/85 mM-sodium acetate) was used to elute the a-subform separately from other forms from CM-Sephadex. This preparation exhibited a specific activity of 170 ,umol * min-' -mg-' and appeared almost pure on gel electrophoresis by the method of Laemmli (1970) .
Apoenzyme
The apoenzyme was prepared by gelfiltering the holoenzyme into water through a solution containing 1 M-NaH2PO4, 50 mM-glutamic acid and 0.2 M-sodium glutamate, pH 4.7. The apoenzyme usually was used within 24 h of preparation.
Aspartate aminotransferase assay
The assay was based on monitoring the production of oxaloacetate by its A260 (Cammarata & Cohen, 1951; see also Jenkins et al., 1959; Velick & Vavra, 1962) ; at this wavelength its molar absorption coefficient is 850 M-l cm-' (Gelles & Hay, 1958) . A solution of 8 mM-2-oxoglutaric acid, 0.2 M-Tris and 0.1 M-HCI was mixed with an equal volume of 20 mM-L-aspartic acid at 25 'C. The reaction was initiated by the addition of enzyme. For measuring specific activities, protein was determined by staining with bicinchoninic acid (Smith et al., 1985) .
Preparation of the holoenzyme analogue
The apoenzyme solution was mixed with a solution containing pyridoxal and arsenate of suitable pH. The mixture was then incubated at room temperature. Regeneration of enzyme activity was monitored by withdrawing samples from the mixture for assay. Since there is low activity of apoenzyme in the presence of pyridoxal alone (Wada & Snell, 1962) , the activity was corrected by subtracting that of a control with pyridoxal under the same conditions. This was under 4 % of the activity regenerated under optimal conditions. The activity was expressed as a percentage of that given by pyridoxal phosphate under optimal conditions 
RESULTS
Conditions for forming the holoenzyme analogue
Effect of arsenate and pyridoxal concentrations. Fig. I shows that 100 mM-arsenate was optimum, and regeneration was less above and below this concentration. Fig. 2 shows that increasing pyridoxal concentration increases the rate and extent of the regeneration of transaminase activity. Higher concentrations of pyridoxal than those shown interfere with the assay for activity by their high absorbance.
Effect of pH. The progress curves differed as the pH was varied over the range 6-9, and the degree of activity regenerated varied by less than 20 %; pH 8.5 seemed to give a slightly better increase of activity than the lower values.
Degree of regeneration. When the best conditions from the previous tests were combined, i.e. 100 mM-arsenate, 10 mMpyridoxal and a pH of 8.5, 640% of the activity obtained with pyridoxal phosphate was reached (Fig. 3) , and this level was achieved in 72 h. It also appears that Tris buffer accelerated regeneration of activity in comparison with merely adjusting the pH of the arsenate solution with NaOH. The apoenzyme was incubated in the presence of 10 mM-pyridoxal and 0.1 M-arsenate in 100 mM-Tris/HCl, pH 8.5, and at room temperature (about 20°C Stability of the holoenzyme analogue formed The holoenzyme formed was stable in the arsenate/pyridoxal mixture for weeks. It was removed from this mixture by gel filtration into water on a column of Sephadex G-25. Over 96 % of the activity loaded on to the column was recovered in the effluent. The transaminase activity in this solution and in the same enzyme solution after the addition of phosphate, arsenate, methylarsonate or Tris/HCl was monitored (Fig. 4) along with those of the other forms (natural holoenzyme and apoenzyme) are shown in Fig. 5 . Although its spectrum differs markedly from that of the natural holoenzyme, it also shows bands centred on 430 nm and 360 nm. The absorption spectra of the pyridoxamine forms are shown in Fig. 6 .
DISCUSSION
Binding of pyridoxal and arsenate
The apoenzyme is known to bind free pyridoxal; indeed, it actually catalyses transamination between pyridoxal and amino acids to form pyridoxamine and oxo acids (Wada & Snell, 1962) . Evidently the pyridoxal and pyridoxamine can bind strongly enough to participate in the reaction, but, unlike their phosphates, weakly enough to be able to dissociate from the enzyme at Vol. 284 neutral pH. Phosphate also binds to the apoenzyme, since it greatly slows the recombination of pyridoxal phosphate (Banks et al., 1963, pp. 212-213; . The latter authors omitted to say how much the re-activation by 10tUM-pyridoxal phosphate in a Tris/HCl buffer was slowed by 0.1 Mphosphate; it changed the half-time of re-activation from about 10 min to about 2 h. Arrio-Dupont (1972), Fonda & Auerbach (1976) and Verge et al. (1979) have since made much more detailed studies of phosphate binding. We have found (results not shown) that arsenate similarly slows the recombination of apoenzyme with pyridoxal phosphate.
Possible esterification at the active site Since the apoenzyme binds both components of pyridoxal arsenate and is likely to place them close to each other, this probably leads to formation of the ester, in view of the fact that esters of arsenic acid form and hydrolyse so easily. Such ester formation, in the light of the tight binding of apoenzyme with pyridoxal phosphate, would explain the stability of the holoenzyme analogue in contrast with the freely reversible dissociation of both pyridoxal and phosphate. Lagunas & Sols (1968) and Lagunas (1970) suggested esterification or a similar reaction to explain why enzymes acted on the unphosphorylated parent compounds of their substrates in the presence of arsenate. Lagunas (1980) , however, doubted whether the action of glucose-6-phosphate dehydrogenase on glucose and arsenate could be so explained (rather than by reaction of the enzyme with the small amounts of glucose 6-arsenate formed in solution), because she found that this dehydrogenase did not accelerate equilibration of glucose and arsenate with glucose 6-arsenate. It is conceivable, however, that the enzyme could accelerate esterification at the active site to give enzyme-bound glucose 6-arsenate and yet be unable to catalyse formation of free glucose 6-arsenate, provided that the dissociation of the ester is slow.
Dissociation and hydrolysis of pyridoxal arsenate
De-esterification of pyridoxal arsenate should be rapid in solution, since nucleoside 5'-arsenates show half-lives of 30-45 min at pH 7 and 25°C (Lagunas et al., 1984) , and glucose 6-arsenate shows one of about 6 min (Lagunas, 1980) . The stability of the holoenzyme analogue shows that the strong binding by the enzyme is enough to prevent the hydrolysis of pyridoxal arsenate. Part of the mechanism of this may be exclusion of water from the neighbourhood of the labile bond (Martinez-Carrion, 1986 ). The binding is expected to be tight, since pyridoxal phosphate does not dissociate from the enzyme appreciably at neutral pH; it appears to be bound with the phospho group predominantly doubly dissociated (Sanchez-Ruiz et al., 1991 , and references cited therein; Korpela et al., 1987) .
The fact that arsenate, phosphate and methylarsonate all aid dissociation of the holoenzyme analogue suggests that, in this analogue, the arsono-oxy group occasionally dissociates from the protein without being hydrolysed from the pyridoxal part of the molecule. Equilibrium must greatly favour its rebinding to the protein in order to explain the great increase in stability of bound pyridoxal arsenate in comparison with free compound. But should not do this. It might however, by the mechanism described, assist the hydrolysis of bound pyridoxal arsenate.
Enzymic activity of the arsenical analogue We can only place a limit on the degree of activity possessed by enzyme that contains pyridoxal arsenate in place of pyridoxal phosphate. We recover 64% of the initial activity by this replacement, but we have no direct evidence of the degree to which the apoenzyme has formed holoenzyme analogue in this treatment. This degree is likely to be high, because addition of pyridoxal phosphate gave only a slight further increase in activity. The somewhat confused absorption spectra of the analogue in both pyridoxal and pyridoxamine forms suggest that we do not have a homogeneous product. Hence the 64 % represents a lower limit on the activity of this analogue. This is remarkable because other replacements of the -0-PO32-group, reviewed by Metzler & Fonda (1985) , e.g. by -CH2-PO32- (Hullar, 1969) , lead to quite low levels of enzyme activity.
